{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:37:38Z","timestamp":1792607858828,"version":"4.5.0"},"reference-count":236,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00388","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:29:46Z","timestamp":1583368186000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":169,"title":["IDO and Kynurenine Metabolites in Peripheral and CNS Disorders"],"prefix":"10.3389","volume":"11","author":[{"given":"Yi-Shu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Ogbechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix I.","family":"Clanchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard O.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1073\/pnas.78.1.129","article-title":"Induction of pulmonary indoleamine 2,3-dioxygenase by interferon","volume":"78","author":"Yoshida","year":"1981","journal-title":"Proc Nat Acad Sci USA."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1126\/science.281.5380.1191","article-title":"Prevention of allogeneic fetal rejection by tryptophan catabolism","volume":"281","author":"Munn","year":"1998","journal-title":"Science."},{"key":"B3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev.immunol.18.1.367","article-title":"Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression","volume":"18","author":"Mellor","year":"2000","journal-title":"Ann Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","article-title":"Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS","volume":"72","author":"Stone","year":"1981","journal-title":"Eur J Pharmacol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/0006-8993(82)91048-4","article-title":"An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid","volume":"247","author":"Perkins","year":"1982","journal-title":"Brain Res"},{"key":"B6","first-page":"551","article-title":"Pharmacology and regional variations of quinolinic acid-evoked excitations in the rat central nervous system","volume":"226","author":"Perkins","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s00726-013-1602-1","article-title":"Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease","volume":"45","author":"Fatokun","year":"2013","journal-title":"Amino Acids."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/art.24446","article-title":"Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1\/Th17 Cells in the joint in collagen-induced arthritis","volume":"60","author":"Criado","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B9","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.4049\/jimmunol.0804116","article-title":"Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4\/B7 and CCL22\/CCR4 interactions","volume":"183","author":"Onodera","year":"2009","journal-title":"J Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1002\/art.38715","article-title":"Treg cell function in rheumatoid arthritis is compromised by CTLA-4 promoter methylation resulting in a failure to activate the indoleamine 2,3-dioxygenase pathway","volume":"66","author":"Cribbs","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/toxsci\/kfq024","article-title":"Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling","volume":"115","author":"DiNatale","year":"2010","journal-title":"Toxicol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"19961","DOI":"10.1073\/pnas.1014465107","article-title":"Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism","volume":"107","author":"Nguyen","year":"2010","journal-title":"Proc Nat Acad Sci USA."},{"key":"B13","doi-asserted-by":"publisher","first-page":"14222","DOI":"10.1073\/pnas.1111786108","article-title":"Aryl hydrocarbon receptor deficiency in T cells suppresses the development of collagen-induced arthritis","volume":"108","author":"Nakahama","year":"2011","journal-title":"Proc Nat Acad Sci USA."},{"key":"B14","doi-asserted-by":"publisher","first-page":"962","DOI":"10.4049\/jimmunol.1502615","article-title":"Tolerogenic phenotype of IFN-g\u2013induced IDO+ dendritic cells is maintained via an autocrine IDO\u2013kynurenine\/ AhR\u2013IDO loop","volume":"197","author":"Li","year":"2016","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.trim.2015.05.003","article-title":"IDO expressing dendritic cells suppress allograft rejection of small bowel transplantation in mice by expansion of Foxp3(+) regulatory T cells","volume":"33","author":"Xie","year":"2015","journal-title":"Transpl Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.4049\/jimmunol.176.11.6752","article-title":"The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells","volume":"176","author":"Fallarino","year":"2006","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.2174\/092986711795656027","article-title":"Using an ancient tool for igniting and propagating immune tolerance: IDO as an inducer and amplifier of regulatory T cell functions","volume":"18","author":"Fallarino","year":"2011","journal-title":"Curr Med Chem"},{"key":"B18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nature06471","article-title":"Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease","volume":"451","author":"Romani","year":"2008","journal-title":"Nature."},{"key":"B19","doi-asserted-by":"publisher","first-page":"5157","DOI":"10.4049\/jimmunol.180.8.5157","article-title":"IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi","volume":"180","author":"Romani","year":"2008","journal-title":"J Immunol"},{"key":"B20","first-page":"445","article-title":"Aromatic hydrocarbon receptor provides a link between smoking and rheumatoid arthritis in peripheral blood mononuclear cells","volume":"37","author":"Cheng","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13075-018-1609-9","article-title":"Smoking-induced aggravation of experimental arthritis is dependent of aryl hydrocarbon receptor activation in Th17 cells","volume":"20","author":"Talbot","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00281-013-0392-6","article-title":"Aryl hydrocarbon receptor and experimental autoimmune arthritis","volume":"35","author":"Nguyen","year":"2013","journal-title":"Semin Immunopathol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jaut.2018.12.004","article-title":"Crosstalk between tumor necrosis factor-alpha signaling and aryl hydrocarbon receptor signaling in nuclear factor -kappa B activation: a possible molecular mechanism underlying the reduced efficacy of TNF-inhibitors in rheumatoid arthritis by smoking","volume":"98","author":"Nii","year":"2019","journal-title":"J Autoimmun"},{"key":"B24","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.1073\/pnas.1722124115","article-title":"Shared epitope-aryl hydrocarbon receptor crosstalk underlies the mechanism of gene-environment interaction in autoimmune arthritis","volume":"115","author":"Fu","year":"2018","journal-title":"Proc Nat Acad Sci USA"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/labinvest.2016.86","article-title":"Sinomenine induces the generation of intestinal Treg cells and attenuates arthritis via activation of aryl hydrocarbon receptor","volume":"96","author":"Tong","year":"2016","journal-title":"Lab Invest"},{"key":"B26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.biocel.2016.03.014","article-title":"Norisoboldine, an isoquinoline alkaloid, acts as an aryl hydrocarbon receptor ligand to induce intestinal Treg cells and thereby attenuate arthritis","volume":"75","author":"Tong","year":"2016","journal-title":"Int J Biochem Cell Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bcp.2015.11.025","article-title":"Tetrandrine ameliorates collagen-induced arthritis in mice by restoring the balance between Th17 and Treg cells via the aryl hydrocarbon receptor","volume":"101","author":"Yuan","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"20223","DOI":"10.1038\/srep20223","article-title":"Notch-regulated miR-223 targets the aryl hydrocarbon receptor pathway and increases cytokine production in macrophages from rheumatoid arthritis patients","volume":"6","author":"Ogando","year":"2016","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1124\/jpet.113.209726","article-title":"Aryl hydrocarbon receptor antagonism attenuates growth factor expression, proliferation, and migration in fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"348","author":"Lahoti","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1178646917691938","DOI":"10.1177\/1178646917691938","article-title":"Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects","volume":"10","author":"Badawy","year":"2017","journal-title":"Int J Tryptophan Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.mehy.2018.06.021","article-title":"Hypothesis kynurenic and quinolinic acids: the main players of the kynurenine pathway and opponents in inflammatory disease","volume":"118","author":"Badawy","year":"2018","journal-title":"Med Hypoth"},{"key":"B32","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2005.03.013","article-title":"GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase","volume":"22","author":"Munn","year":"2005","journal-title":"Immunity."},{"key":"B33","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.4049\/jimmunol.1001628","article-title":"IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis","volume":"185","author":"Yan","year":"2010","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1126\/science.1246829","article-title":"Vaccine activation of the nutrient sensor GCN2 in dendritic cells enhances antigen presentation","volume":"343","author":"Ravindran","year":"2014","journal-title":"Science."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1016\/j.celrep.2016.10.079","article-title":"Stress kinase GCN2 controls the proliferative fitness and trafficking of cytotoxic T cells independent of environmental amino acid sensing","volume":"17","author":"van de Velde","year":"2016","journal-title":"Cell Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1111\/j.1440-1681.2006.04490.x","article-title":"Kynurenine pathway metabolism in patients with osteoporosis after two years of drug treatment","volume":"33","author":"Forrest","year":"2006","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/j.1471-4159.1990.tb04553.x","article-title":"Presence of 3-hydroxyanthranilic acid in rat-tissues and evidence for its production from anthranilic acid in the brain","volume":"55","author":"Baran","year":"1990","journal-title":"J Neurochem"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/sj.cdd.4401073","article-title":"T cell apoptosis by tryptophan catabolism","volume":"9","author":"Fallarino","year":"2002","journal-title":"Cell Death Differ."},{"key":"B39","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000431091","article-title":"Immunology of osteoporosis: a mini-review","volume":"62","author":"Pietschmann","year":"2016","journal-title":"Gerontology."},{"key":"B40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bonr.2017.10.003","article-title":"Is osteoporosis an autoimmune mediated disorder?","volume":"7","author":"Iseme","year":"2017","journal-title":"Bone Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.autrev.2008.07.038","article-title":"Osteoimmunology\u2013the hidden immune regulation of bone","volume":"8","author":"Caetano-Lopes","year":"2009","journal-title":"Autoimmun Rev"},{"key":"B42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4137\/IJTR.S4282","article-title":"On the biological importance of the 3-hydroxyanthranilic acid: anthranilic acid ratio","volume":"3","author":"Darlington","year":"2010","journal-title":"Int J Tryptophan Res"},{"key":"B43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0006-2952(87)90691-5","article-title":"Oxidative reactivity of the tryptophan metabolites 3-hydroxyanthranilate, quinolinate and picolinate","volume":"36","author":"Dykens","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-9861(90)90034-V","article-title":"Superoxide disumutases enhance the rat of autoxidation of 3-hydroxyanthranilic acid","volume":"276","author":"Ishii","year":"1990","journal-title":"Arch Biochem Biophys"},{"key":"B45","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/infdis\/jiw623","article-title":"Kynurenine pathway activation in human african trypanosomiasis","volume":"215","author":"Sternberg","year":"2017","journal-title":"J Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1042\/bj0530513","article-title":"The relation between riboflavin and tryptophan metabolism, studied in the rat","volume":"53","author":"Charconnet-Harding","year":"1953","journal-title":"Biochem J"},{"key":"B47","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0021-9258(18)98156-1","article-title":"Riboflavin and hepatic kynurenine hydroxylase","volume":"234","author":"Stevens","year":"1959","journal-title":"J Biol Chem"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/S0026-0495(99)90253-6","article-title":"Tissue distribution and turnover of [3H]riboflavin during respiratory infection in mice","volume":"48","author":"Brijal","year":"1999","journal-title":"Metabolism."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.pharep.2017.04.011","article-title":"Thiamine and riboflavin inhibit production of cytokines and increase the anti-inflammatory activity of a corticosteroid in a chronic model of inflammation induced by complete freund's adjuvant","volume":"69","author":"Menezes","year":"2017","journal-title":"Pharmacol Rep"},{"key":"B50","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12950-016-0145-0","article-title":"Riboflavin along with antibiotics balances reactive oxygen species and inflammatory cytokines and controls Staphylococcus aureus infection by boosting murine macrophage function and regulates inflammation","volume":"13","author":"Dey","year":"2016","journal-title":"J Inflamm."},{"key":"B51","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1126\/science.89.2312.368","article-title":"The loss of resistance to murine typhus infection resulting from riboflavin deficiency in rats","volume":"89","author":"Pinkerton","year":"1939","journal-title":"Science."},{"key":"B52","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s00011-005-1372-7","article-title":"Riboflavin in innate and acquired immune responses","volume":"54","author":"Verdrengh","year":"2005","journal-title":"Inflamm Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1136\/ard.55.11.837","article-title":"Glutathione reductase activity, riboflavin status, and disease activity in rheumatoid arthritis","volume":"55","author":"Mulherin","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1620\/tjem.153.79","article-title":"Alteration of tryptophan-metabolism in the synovial-fluid of patients with rheumatoid-arthritis and osteoarthritis","volume":"153","author":"Igari","year":"1987","journal-title":"Tohoku J Exp Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.3390\/molecules23102600","article-title":"Isopsoralen enhanced osteogenesis by targeting AhR\/ER\u03b1","volume":"23","author":"Ge","year":"2018","journal-title":"Molecules."},{"key":"B56","first-page":"779","article-title":"New insights into tryptophan and its metabolites in the regulation of bone metabolism","volume":"66","author":"Michalowska","year":"2015","journal-title":"J Physiol Pharmacol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3389\/fphys.2017.00836","article-title":"Elevated levels of peripheral kynurenine decrease bone strength in rats with chronic kidney disease","volume":"8","author":"Kalaska","year":"2017","journal-title":"Front Physiol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"11115","DOI":"10.1073\/pnas.1220919110","article-title":"Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes","volume":"110","author":"Iqbal","year":"2013","journal-title":"Proc Nat Acad Sci USA"},{"key":"B59","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.yexcr.2016.12.009","article-title":"Aryl hydrocarbon receptor suppresses the osteogenesis of mesenchymal stem cells in collagen-induced arthritic mice through the inhibition of beta-catenin","volume":"350","author":"Tong","year":"2017","journal-title":"Exp Cell Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jphs.2014.11.006","article-title":"3,3 '-Diindolylmethane increases bone mass by suppressing osteoclastic bone resorption in mice","volume":"127","author":"Yu","year":"2015","journal-title":"J Pharmacol Sci"},{"key":"B61","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/art.38319","article-title":"CTLA-4Ig-Induced T cell anergy promotes Wnt-10b production and bone formation in a mouse model","volume":"66","author":"Roser-Page","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"15087","DOI":"10.1073\/pnas.0703610104","article-title":"Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation","volume":"104","author":"Grassi","year":"2007","journal-title":"Proc Nat Acad Sci USA."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1136\/ard.2007.080713","article-title":"CTLA-4 directly inhibits osteoclast formation","volume":"67","author":"Axmann","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"B64","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00223-018-0401-9","article-title":"Osteoporosis in rheumatic diseases: anti-rheumatic drugs and the skeleton","volume":"102","author":"Dubrovsky","year":"2018","journal-title":"Calcif Tissue Int"},{"key":"B65","doi-asserted-by":"publisher","first-page":"235ra60","DOI":"10.1126\/scitranslmed.3007764","article-title":"T cell costimulation molecules CD80\/86 inhibit osteoclast differentiation by inducing the IDO\/Tryptophan pathway","volume":"6","author":"Bozec","year":"2014","journal-title":"Sci Transl Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11914-017-0356-1","article-title":"T regulatory cells in bone remodelling","volume":"15","author":"Bozec","year":"2017","journal-title":"Curr Osteoporos Rep"},{"key":"B67","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5582\/bst.2015.01073","article-title":"DHEA promotes osteoblast differentiation by regulating the expression of osteoblast-related genes and Foxp(3+) regulatory T cells","volume":"9","author":"Qiu","year":"2015","journal-title":"Biosci Trends."},{"key":"B68","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/toxsci\/kfp044","article-title":"The Aryl hydrocarbon receptor activator benzo[a]pyrene enhances vitamin D-3 catabolism in macrophages","volume":"109","author":"Matsunawa","year":"2009","journal-title":"Toxicol Sci"},{"key":"B69","doi-asserted-by":"publisher","first-page":"13033","DOI":"10.1073\/pnas.1517820112","article-title":"Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development","volume":"112","author":"Cole","year":"2015","journal-title":"Proc Nat Acad Sci USA."},{"key":"B70","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/cvr\/cvv100","article-title":"Inhibition of indoleamine-2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in apoE-\/- mice","volume":"106","author":"Polyzos","year":"2015","journal-title":"Cardiovasc Res"},{"key":"B71","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3389\/fimmu.2018.00950","article-title":"Activation of the regulatory T-cell\/indoleamine-2,3-dioxygenase axis reduces vascular inflammation and atherosclerosis in hypoerlipidemic mice","volume":"9","author":"Forteza","year":"2018","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cmet.2016.04.010","article-title":"Indoleamine-2,3-dioxygenase-expressing plasmacytoid dendritic cells protect against atherosclerosis by induction of regulatory T cells","volume":"23","author":"Yun","year":"2016","journal-title":"Cell Metab"},{"key":"B73","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection","volume":"78","author":"Guillemin","year":"2001","journal-title":"J Neurochem"},{"key":"B74","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1365-2990.2005.00655.x","article-title":"Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus","volume":"31","author":"Guillemin","year":"2005","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0165-5728(01)00418-0","article-title":"Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages","volume":"120","author":"Chiarugi","year":"2001","journal-title":"J Neuroimmunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1042\/bj2830633","article-title":"Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid","volume":"283","author":"Heyes","year":"1992","journal-title":"Biochem J."},{"key":"B77","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/glia.20090","article-title":"Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons","volume":"49","author":"Guillemin","year":"2005","journal-title":"Glia."},{"key":"B78","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000499736","article-title":"Assessment of prenatal kynurenine metabolism using tissue slices: focus on the neosynthesis of kynurenic acid in mice","volume":"41","author":"Notarangelo","year":"2019","journal-title":"Dev Neurosci"},{"key":"B79","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.brainresbull.2018.12.014","article-title":"Investigating kynurenic acid production and kynurenergic manipulation on acute mouse brain slice preparations","volume":"146","author":"Heredi","year":"2019","journal-title":"Brain Res Bull"},{"key":"B80","first-page":"309","article-title":"The neuropharmacology of quinolinic and kynurenic acids","volume":"45","author":"Stone","year":"1993","journal-title":"Pharmacol Rev"},{"key":"B81","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrd870","article-title":"Endogenous kynurenines as targets for drug discovery and development","volume":"1","author":"Stone","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"B82","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tips.2012.09.006","article-title":"An expanding range of targets for kynurenine metabolites of tryptophan","volume":"34","author":"Stone","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"B83","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1126\/science.6849138","article-title":"Quinolinic acid - an endogenous metabolite that produces axon-sparing lesions in rat brain","volume":"219","author":"Schwarcz","year":"1983","journal-title":"Science."},{"key":"B84","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1742-2094-6-36","article-title":"Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease","volume":"6","author":"Ting","year":"2009","journal-title":"J Neuroinflammation"},{"key":"B85","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.neuropharm.2016.03.024","article-title":"Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases","volume":"112","author":"Lovelace","year":"2017","journal-title":"Neuropharmacology."},{"key":"B86","doi-asserted-by":"publisher","first-page":"R1345","DOI":"10.1152\/ajpregu.00268.2005","article-title":"Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA \/ GABA(A) dysregulation and impaired spatial learning","volume":"290","author":"Samuelsson","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3934\/molsci.2015.2.77","article-title":"Glutamate\/NMDA excitoxicity and HMGB1\/TLR4 neuroimmune toxicity converge as components of neurodegeneration","volume":"2","author":"Zou","year":"2015","journal-title":"AIMS Mol Sci"},{"key":"B88","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/ana.410270614","article-title":"Increased ratio of quinolinic acid to kynurenic acid in cerebrospinal-fluid of d-retrovirus-infected rhesus macaques - relationship to clinical and viral status","volume":"27","author":"Heyes","year":"1990","journal-title":"Ann Neurol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0006-8993(92)90587-Y","article-title":"Relationship of neurologic status in macaques infected with the simian immunodeficiency virus to cerebrospinal-fluid quinolinic acid and kynurenic acid","volume":"570","author":"Heyes","year":"1992","journal-title":"Brain Res"},{"key":"B90","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1073\/pnas.81.3.908","article-title":"Interferon-gamma blocks the growth of toxoplasma-gondii in human-fibroblasts by inducing the host-cells to degrade tryptophan","volume":"81","author":"Pfefferkorn","year":"1984","journal-title":"Proc Nat Acad Sci USA."},{"key":"B91","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1084\/jem.20020052","article-title":"Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites","volume":"196","author":"Terness","year":"2002","journal-title":"J Exp Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.it.2005.12.006","article-title":"The immunoregulatory role of IDO-producing human dendritic cells revisited","volume":"27","author":"Terness","year":"2006","journal-title":"Trends Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/ng1542","article-title":"A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease","volume":"37","author":"Giorgini","year":"2005","journal-title":"Nat Genet"},{"key":"B94","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.pneurobio.2009.04.005","article-title":"Of mice, rats and men: revisiting the quinolinic acid hypothesis of Huntington's disease","volume":"90","author":"Schwarcz","year":"2010","journal-title":"Prog Neurobiol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/j.1471-4159.2005.03070.x","article-title":"Tryptophan metabolism and oxidative stress in patients with Huntington's disease","volume":"93","author":"Stoy","year":"2005","journal-title":"J Neurochem"},{"key":"B96","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/14728222.2019.1549231","article-title":"Indoleamine-2,3-dioxygenase as a novel therapeutic target for Huntingon's disease","volume":"23","author":"Boros","year":"2019","journal-title":"Exp Opin Ther Targets."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/j.1742-4658.2012.08487.x","article-title":"Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection","volume":"279","author":"Stone","year":"2012","journal-title":"FEBS J"},{"key":"B98","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00702-011-0676-8","article-title":"Involvement of kynurenines in Huntington's disease and stroke-induced brain damage","volume":"119","author":"Stone","year":"2012","journal-title":"J Neural Transm."},{"key":"B99","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.coph.2015.09.008","article-title":"Disruption of immune cell function by mutant huntingtin in Huntington's disease pathogenesis","volume":"26","author":"Andre","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1471-4159.2009.06442.x","article-title":"Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington's disease","volume":"112","author":"Forrest","year":"2010","journal-title":"J Neurochem"},{"key":"B101","doi-asserted-by":"publisher","first-page":"541259","DOI":"10.1155\/2013\/541259","article-title":"The role of the immune system in Huntington's disease","volume":"2013","author":"Ellrichmann","year":"2013","journal-title":"Clin. Dev. Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1111\/j.1471-4159.2010.06675.x","article-title":"Dysfunctional kynurenine pathway metabolism in the R6\/2 mouse model of Huntington's disease","volume":"113","author":"Sathyasaikumar","year":"2010","journal-title":"J Neurochem"},{"key":"B103","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.it.2015.04.007","article-title":"The choreography of neuroinflammation in Huntington's disease","volume":"36","author":"Crotti","year":"2015","journal-title":"Trends Immunol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"44849","DOI":"10.1038\/srep44849","article-title":"Huntington's disease blood and brain show a common gene expression pattern and share an immune signature with Alzheimer's disease","volume":"7","author":"Moss","year":"2017","journal-title":"Sci Rep"},{"key":"B105","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.brainres.2017.08.013","article-title":"Beneficial effects of glatiramer acetate in Huntington's disease mouse models: evidence for BDNF-elevating and immunomodulatory mechanisms","volume":"1673","author":"Corey-Bloom","year":"2017","journal-title":"Brain Res"},{"key":"B106","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/eji.201646564","article-title":"HLA-G promotes myeloid-derived suppressor cell accumulation and suppressive activity during human pregnancy through engagement of the receptor ILT4","volume":"47","author":"Kostlin","year":"2017","journal-title":"Eur J Immunol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1093\/brain\/awh609","article-title":"Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity","volume":"128","author":"Wiendl","year":"2005","journal-title":"Brain."},{"key":"B108","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1191\/1352458506ms1241oa","article-title":"Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis","volume":"12","author":"Fainardi","year":"2006","journal-title":"Mult Scler"},{"key":"B109","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s12015-011-9312-0","article-title":"Immunosuppressive properties of mesenchymal stem cells","volume":"8","author":"Abumaree","year":"2012","journal-title":"Stem Cell Rev Rep"},{"key":"B110","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/01.tp.0000267918.07906.08","article-title":"Immuno-suppressive effects of mesenchymal stem cells: involvement of HLA-G","volume":"84","author":"Nasef","year":"2007","journal-title":"Transplantation."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S1470-2045(19)30274-8","article-title":"Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301\/KEYNOTE-252): a phase 3, randomised, double-blind study","volume":"20","author":"Long","year":"2019","journal-title":"Lancet Oncol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.3389\/fimmu.2019.01801","article-title":"Limitations and off-target effects of tryptophan-related IDO inhibitors in cancer treatment","volume":"10","author":"Guenther","year":"2019","journal-title":"Front Immunol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3389\/fonc.2018.00423","article-title":"Updates in the clinical development of epacadostat and other indoleamine 2,3-dioxygenase 1 inhibitors (IDO1) for human cancers","volume":"8","author":"Komiya","year":"2018","journal-title":"Front Oncol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1189\/jlb.1112589","article-title":"IFN- \u03b3-rich environment programs dendritic cells toward silencing of cytotoxic immune responses","volume":"95","author":"Svajger","year":"2014","journal-title":"J Leukoc Biol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.4049\/jimmunol.176.5.2857","article-title":"Self-limitation of Th1-mediated inflammation by IFN-gamma","volume":"176","author":"Feuerer","year":"2006","journal-title":"J Immunol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1093\/humrep\/dev196","article-title":"Soluble human leukocyte antigen G5 polarizes differentiation of macrophages toward a decidual macrophage-like phenotype","volume":"30","author":"Lee","year":"2015","journal-title":"Hum Reprod."},{"key":"B117","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.4049\/jimmunol.0713732r","article-title":"M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than M1 Cells In vitro","volume":"182","author":"Leidi","year":"2009","journal-title":"J Immunol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.mce.2017.05.015","article-title":"Medroxyprogesterone acetate drives M2 macrophage differentiation toward a phenotype of decidual macrophage","volume":"452","author":"Tsai","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"e0191040","DOI":"10.1371\/journal.pone.0191040","article-title":"VEGF may contribute to macrophage recruitment and M2 polarization in the decidua","volume":"13","author":"Wheeler","year":"2018","journal-title":"PLoS ONE."},{"key":"B120","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/978-1-4615-0135-0_4","article-title":"Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes","volume":"41","author":"Guillemin","year":"2003","journal-title":"Glia."},{"key":"B121","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/BF03401753","article-title":"Amyloid-beta induces chemokine secretion and monocyte migration across a human blood-brain barrier model","volume":"4","author":"Fiala","year":"1998","journal-title":"Mol Med"},{"key":"B122","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1097\/00001756-200312190-00005","article-title":"A beta 1-42 induces production of quinolinic acid by human macrophages and microglia","volume":"14","author":"Guillemin","year":"2003","journal-title":"Neuroreport."},{"key":"B123","doi-asserted-by":"publisher","first-page":"167.e176","DOI":"10.1007\/978-1-4615-0135-0_19","article-title":"Quinolinic acid in the pathogenesis of Alzheimer's disease","volume":"527","author":"Guillemin","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF03033908","article-title":"The involvement of astrocytes and kynurenine pathway in Alzheimer's disease","volume":"12","author":"Ting","year":"2007","journal-title":"Neurotox Res"},{"key":"B125","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s007020050029","article-title":"Tryptophan degradation and immune activation in Alzheimer's disease","volume":"107","author":"Widner","year":"2000","journal-title":"J Neural Transm."},{"key":"B126","doi-asserted-by":"publisher","first-page":"e59749","DOI":"10.1371\/journal.pone.0059749","article-title":"Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS ONE."},{"key":"B127","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1742-2094-2-16","article-title":"Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex","volume":"2","author":"Guillemin","year":"2005","journal-title":"J Neuroinflammation"},{"key":"B128","doi-asserted-by":"publisher","first-page":"e6344","DOI":"10.1371\/journal.pone.0006344","article-title":"The excitotoxin quinolinic acid induces tau phosphorylation in human neurons","volume":"4","author":"Rahman","year":"2009","journal-title":"PLoS ONE."},{"key":"B129","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.4049\/jimmunol.164.6.3283","article-title":"The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1 alpha and-1 beta in macrophages","volume":"164","author":"Bosco","year":"2000","journal-title":"J Immunol"},{"key":"B130","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.4049\/jimmunol.150.9.4031","article-title":"Picolinic-acid, a catabolite of l-tryptophan, a costimulus for the induction of reactive nitrogen intermediate production in murine macrophages","volume":"150","author":"Melillo","year":"1993","journal-title":"J Immunol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"12884","DOI":"10.1523\/JNEUROSCI.4101-07.2007","article-title":"Characterization of the kynurenine pathway in human neurons","volume":"27","author":"Guillemin","year":"2007","journal-title":"J Neurosci"},{"key":"B132","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0006-8993(90)90826-W","article-title":"Quinolinate-induced cortical cholinergic damage - modulation by tryptophan-metabolites","volume":"529","author":"Jhamandas","year":"1990","journal-title":"Brain Res"},{"key":"B133","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0006-8993(93)90320-M","article-title":"Picolinic-acid modulates kainic acid-evoked glutamate release from the striatum in-vitro","volume":"627","author":"Vrooman","year":"1993","journal-title":"Brain Res"},{"key":"B134","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/0306-4522(94)90438-3","article-title":"Picolinic-acid blocks the neurotoxic but not the neuroexcitant properties of quinolinic acid in the rat-brain - evidence from turning behavior and tyrosine-hydroxylase immunohistochemistry","volume":"61","author":"Beninger","year":"1994","journal-title":"Neuroscience"},{"key":"B135","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.neuropharm.2016.01.034","article-title":"Kynurenine pathway metabolites and suicidality","volume":"112","author":"Bryleva","year":"2017","journal-title":"Neuropharmacology."},{"key":"B136","doi-asserted-by":"publisher","first-page":"e0130715","DOI":"10.1371\/journal.pone.0130715","article-title":"Indoleamine 2,3 dioxygenase (IDO) expression and activity in relapsing-remitting multiple sclerosis","volume":"10","author":"Mancuso","year":"2015","journal-title":"PLoS ONE."},{"key":"B137","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4137\/IJTR.S4294","article-title":"Understanding the roles of the kynurenine pathway in multiple sclerosis progression","volume":"3","author":"Lim","year":"2010","journal-title":"Int J Tryptophan Res"},{"key":"B138","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1117634","article-title":"Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite","volume":"310","author":"Platten","year":"2005","journal-title":"Science."},{"key":"B139","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1600-0404.2005.00442.x","article-title":"Kynurenine metabolism in multiple sclerosis","volume":"112","author":"Hartai","year":"2005","journal-title":"Acta Neurol Scand"},{"key":"B140","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0306-4522(00)00504-2","article-title":"Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis","volume":"102","author":"Chiarugi","year":"2001","journal-title":"Neuroscience."},{"key":"B141","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0165-5728(02)00176-5","article-title":"Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis","volume":"129","author":"Sakurai","year":"2002","journal-title":"J Neuroimmunol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1096\/fj.04-3228fje","article-title":"Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation","volume":"19","author":"Kwidzinski","year":"2005","journal-title":"FASEB J"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s00109-007-0229-7","article-title":"IDO expression in the brain: a double-edged sword","volume":"85","author":"Kwidzinski","year":"2007","journal-title":"J Mol Med"},{"key":"B144","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.psyneuen.2015.07.609","article-title":"Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder","volume":"62","author":"Savitz","year":"2015","journal-title":"Psychoneuroendocrinology."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/bph.12230s","article-title":"The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders","volume":"169","author":"Stone","year":"2013","journal-title":"Br J Pharmacol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.neuropharm.2016.05.020","article-title":"The kynurenine pathway in schizophrenia and bipolar disorder","volume":"112","author":"Erhardt","year":"2017","journal-title":"Neuropharmacology."},{"key":"B147","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/archgenpsychiatry.2011.71.","article-title":"Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes","volume":"68","author":"Wonodi","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/j.1471-4159.2008.05241.x","article-title":"Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity","volume":"105","author":"Owe-Young","year":"2008","journal-title":"J Neurochem"},{"key":"B149","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3109\/15622975.2011.583941","article-title":"Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity","volume":"13","author":"Steiner","year":"2012","journal-title":"World J Biol Chem"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","article-title":"Quinolinic acid, the inescapable neurotoxin","volume":"79","author":"Guillemin","year":"2012","journal-title":"FEBS J"},{"key":"B151","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0361-9230(00)00368-3","article-title":"Quinolinic acid enhances permeability of rat brain microvessels to plasma albumin","volume":"53","author":"St'astn\u00fd","year":"2000","journal-title":"Brain Res Bull"},{"key":"B152","doi-asserted-by":"publisher","first-page":"43642","DOI":"10.1038\/srep43642","article-title":"Beta-trace protein as a new noninvasive immunological marker for quinolinic acid-induced blood-brain barrier integrity","volume":"7","author":"Baranyi","year":"2017","journal-title":"Sci Rep"},{"key":"B153","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2147\/DDDT.S44496","article-title":"Unexpected effects of peripherally administered kynurenic acid on cortical spreading depression and related blood-brain barrier permeability","volume":"7","author":"Olah","year":"2013","journal-title":"Drug Des Dev Ther."},{"key":"B154","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11011-008-9118-1","article-title":"The inflammatory and neurodegenerative hypothesis of depression: leads for future research and new drug developments in depression","volume":"24","author":"Maes","year":"2009","journal-title":"Metab Brain Dis."},{"key":"B155","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.psyneuen.2010.09.012","article-title":"Inflammation-associated depression: from serotonin to kynurenine","volume":"36","author":"Dantzer","year":"2011","journal-title":"Psychoneuroendocrinology."},{"key":"B156","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jpsychires.2015.05.007","article-title":"Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: evidences from animal and human studies","volume":"68","author":"Reus","year":"2015","journal-title":"J Psychiat Res"},{"key":"B157","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1007\/s00213-019-05200-8","article-title":"Inflammation in cancer and depression: a starring role for the kynurenine pathway","volume":"236","author":"Sforzini","year":"2019","journal-title":"Psychopharmacology."},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.14907","article-title":"Does kynurenic acid act on nicotinic receptors?","author":"Stone","year":"","journal-title":"An assessment of the evidence. J. Neurochem."},{"key":"B159","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/da.22084","article-title":"Cytokine targets in the brain: impact on neurotransmitters and neurocircuits","volume":"30","author":"Miller","year":"2013","journal-title":"Depress Anxiety."},{"key":"B160","doi-asserted-by":"publisher","first-page":"5249","DOI":"10.1128\/IAI.73.8.5249-5251.2005","article-title":"Prolonged survival of a murine model of cerebral malaria by kynurenine pathway inhibition","volume":"73","author":"Clark","year":"2005","journal-title":"Infect Immun."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2013.01.031","article-title":"Prenatal inhibition of the tryptophan - kynurenine pathway alters synaptic plasticity and protein expression in the rat hippocampus","volume":"1504","author":"Forrest","year":"2013","journal-title":"Brain Res"},{"key":"B162","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neuroscience.2013.09.034","article-title":"Changes in synaptic transmission and protein expression in the brains of adult offspring after prenatal inhibition of the kynurenine pathway","volume":"254","author":"Forrest","year":"2013","journal-title":"Neuroscience."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1111\/ejn.12535","article-title":"Prenatal inhibition of the kynurenine pathway leads to structural changes in the hippocampus of adult rat offspring","volume":"39","author":"Khalil","year":"2014","journal-title":"Euro J Neurosci"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2014.06.016","article-title":"Modified neocortical and cerebellar protein expression and morphology following prenatal inhibition of the kynurenine pathway","volume":"1576","author":"Pisar","year":"2014","journal-title":"Brain Res"},{"key":"B165","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neuroscience.2015.09.022","article-title":"Altered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamine","volume":"310","author":"Forrest","year":"2015","journal-title":"Neuroscience."},{"key":"B166","doi-asserted-by":"publisher","first-page":"36554","DOI":"10.1074\/jbc.M113.503813","article-title":"Targeted deletion of kynurenine 3-monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain","volume":"288","author":"Giorgini","year":"2013","journal-title":"J Biol Chem"},{"key":"B167","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1093\/brain\/awp074","article-title":"Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis","volume":"132","author":"Rodgers","year":"2009","journal-title":"Brain."},{"key":"B168","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/tri.13023","article-title":"Mesenchymal stem cells attenuate liver fibrosis by suppressing Th17 cells - an experimental study","volume":"31","author":"Milosavljevic","year":"2018","journal-title":"Transpl Int"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1315378","DOI":"10.1155\/2017\/1315378","article-title":"Mesenchymal stem cells attenuate cisplatin-induced nephrotoxicity in iNOS-dependent manner","volume":"2017","author":"Markovic","year":"2017","journal-title":"Stem Cells Int."},{"key":"B170","doi-asserted-by":"publisher","first-page":"6294717","DOI":"10.1155\/2017\/6294717","article-title":"Mesenchymal stem cells promote metastasis of lung cancer cells by downregulating systemic antitumor immune response","volume":"2017","author":"Gazdic","year":"2017","journal-title":"Stem Cells Int."},{"key":"B171","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/labinvest.2016.74","article-title":"Functional expression of aryl hydrocarbon receptor on mast cells populating human endometriotic tissues","volume":"96","author":"Mariuzzi","year":"2016","journal-title":"Lab Invest"},{"key":"B172","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.3945\/jn.116.230698","article-title":"Serum immune system biomarkers neopterin and interleukin-10 are strongly related to tryptophan metabolism in healthy young adults","volume":"146","author":"Deac","year":"2016","journal-title":"J Nutr"},{"key":"B173","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.3390\/ijms19103009","article-title":"Effects of 1-methyltryptophan on immune responses and the kynurenine pathway after lipopolysaccharide challenge in pigs","volume":"19","author":"Wirthgen","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1642912","DOI":"10.1155\/2017\/1642912","article-title":"Functional bowel disorders are associated with a central immune activation","volume":"2017","author":"Farup","year":"2017","journal-title":"Gastroenterol Res Pract."},{"key":"B175","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00262-016-1945-z","article-title":"Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer","volume":"66","author":"Pichler","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"B176","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12974-014-0169-4","article-title":"The kynurenine pathway is involved in bacterial meningitis","volume":"11","author":"Coutinho","year":"2014","journal-title":"J Neuroinflamm."},{"key":"B177","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.cmet.2015.07.004","article-title":"Indoleamine 2,3-dioxygenase fine-tunes immune homeostasis in atherosclerosis and colitis through repression of interleukin-10 production","volume":"22","author":"Metghalchi","year":"2015","journal-title":"Cell Metab"},{"key":"B178","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/cea.12067","article-title":"Statins enhance the effects of corticosteroids on the balance between regulatory T cells and Th17 cells","volume":"43","author":"Maneechotesuwan","year":"2013","journal-title":"Clin Exp Allergy."},{"key":"B179","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3389\/fimmu.2017.00880","article-title":"The IDO-AHR axis controls Th17\/treg immunity in a pulmonary model of fungal infection","volume":"8","author":"de Araujo","year":"2017","journal-title":"Front Immunol"},{"key":"B180","doi-asserted-by":"publisher","first-page":"15228","DOI":"10.1038\/s41598-017-15079-0","article-title":"Clinical parameters and gut microbiome changes before and after surgery in thoracic aortic dissection in patients with gastrointestinal complications","volume":"7","author":"Zheng","year":"2017","journal-title":"Sci Rep"},{"key":"B181","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.pharep.2017.02.020","article-title":"Effects of tryptophan, kynurenine and kynurenic acid exerted on human reconstructed corneal epithelium in vitro","volume":"69","author":"Matysik-Wozniak","year":"2017","journal-title":"Pharmacol Rep"},{"key":"B182","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.pnpbp.2017.04.026","article-title":"Effect of antidepressant treatment on peripheral inflammation markers - a meta-analysis","volume":"80","author":"Wiedlocha","year":"2018","journal-title":"Progr Neuropsychopharmacol Biol Psychiatry"},{"key":"B183","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.psychres.2015.07.009","article-title":"Plasma cytokine abnormalities in drug-naive, comorbidity-free obsessive-compulsive disorder","volume":"229","author":"Rao","year":"2015","journal-title":"Psychiatry Res"},{"key":"B184","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/jmv.25083","article-title":"The role of IDO, IL-10 and TGF-\u03b2 in the HCV-associated chronic hepatitis, liver cirrhosis and hepatocellular carcinoma","volume":"91","author":"Yang","year":"2019","journal-title":"J Med Virol"},{"key":"B185","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/mi.2016.133","article-title":"Tryptophan metabolite activation of the aryl hydrocarbon receptor regulates IL-10 receptor expression on intestinal epithelia","volume":"10","author":"Lanis","year":"2017","journal-title":"Mucosal Immunol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cellimm.2019.03.003","article-title":"LPS enhances CTB-insulin induction of IDO1 and IL-10 synthesis in human dendritic cells","volume":"338","author":"Kim","year":"2019","journal-title":"Cell Immunol"},{"key":"B187","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1136\/gut.2008.162842","article-title":"Anti-CTLA-4 treatment induces IL-10-producing ICOS+ regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis","volume":"58","author":"Coquerelle","year":"2009","journal-title":"Gut."},{"key":"B188","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2174\/1574888X113086660067","article-title":"Human amniotic fluid stem cells suppress PBMC proliferation through IDO and IL-10-dependent pathways","volume":"9","author":"Luo","year":"2014","journal-title":"Curr Stem Cell Res Ther."},{"key":"B189","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fimmu.2019.00143","article-title":"Faecalibacterium prausnitzii skews human DC to prime IL10-producing T cells through TLR2\/6\/JNK signalling and IL-10, IL-27, CD39 and IDO-1 induction","volume":"10","author":"Alameddine","year":"2019","journal-title":"Front Immunol"},{"key":"B190","doi-asserted-by":"publisher","first-page":"6102","DOI":"10.4049\/jimmunol.1303144","article-title":"S100A4 and uric acid promote mesenchymal stromal cell induction of IL-10(+)\/IDO+ lymphocytes","volume":"192","author":"Eisenbacher","year":"2014","journal-title":"J Immunol"},{"key":"B191","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1038\/sj.onc.1210939","article-title":"A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine-2,3-dioxygenase","volume":"27","author":"Banerjee","year":"2008","journal-title":"Oncogene."},{"key":"B192","doi-asserted-by":"publisher","first-page":"32824","DOI":"10.1074\/jbc.272.52.32824","article-title":"Expression of the human aryl hydrocarbon receptor complex in yeast. Activation of transcription by indole compounds","volume":"272","author":"Miller","year":"1997","journal-title":"J Biol Chem"},{"key":"B193","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.abb.2004.01.002","article-title":"Aryl hydrocarbon receptor response to indigoids in vitro and in vivo","volume":"423","author":"Guengerich","year":"2004","journal-title":"Arch Biochem Biophys"},{"key":"B194","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/toxsci\/kfq360","article-title":"Aryl hydrocarbon receptor activation by tcdd reduces inflammation associated with Crohn's Disease","volume":"120","author":"Benson","year":"2011","journal-title":"Toxicol Sci"},{"key":"B195","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/toxsci\/kfr249","article-title":"Dietary ligands of the aryl hydrocarbon receptor induce anti-inflammatory and immunoregulatory effects on murine dendritic cells","volume":"124","author":"Benson","year":"2011","journal-title":"Toxicol Sci"},{"key":"B196","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neuropharm.2016.03.001","article-title":"Elevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behaviour","volume":"112","author":"Notarangelo","year":"2017","journal-title":"Neuropharmacology."},{"key":"B197","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1007\/s00213-014-3452-2","article-title":"Continuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult rats","volume":"231","author":"Pocivavsek","year":"2014","journal-title":"Psychopharmacology."},{"key":"B198","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hipo.23040","article-title":"Inhibition of kynurenine aminotransferase II attenuates hippocampus-dependent memory deficit in adult rats treated prenatally with kynurenine","volume":"29","author":"Pocivavsek","year":"2019","journal-title":"Hippocampus."},{"key":"B199","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00213-017-4780-9","article-title":"Prenatal kynurenine treatment in rats causes schizophrenia-like broad monitoring deficits in adulthood","volume":"235","author":"Hahn","year":"2018","journal-title":"Psychopharmacology."},{"key":"B200","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1503\/jpn.140126","article-title":"Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia - significance for activation of the kynurenine pathway","volume":"40","author":"Schwieler","year":"2015","journal-title":"J Psychiat Neurosci"},{"key":"B201","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.pnpbp.2012.06.014","article-title":"Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neuro-development and neuroprogression","volume":"42","author":"Anderson","year":"2013","journal-title":"Progr Neuropsychopharmacol Biol Psychiatry"},{"key":"B202","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ntt.2014.10.007","article-title":"Prenatal immune challenge in rats: Effects of polyinosinic\u2013polycytidylic acid on spatial learning, prepulse inhibition, conditioned fear, and responses to MK-801 and amphetamine","volume":"47","author":"Vorhees","year":"2015","journal-title":"Neurotoxicol Teratol"},{"key":"B203","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bbi.2016.07.144","article-title":"Effects of immune activation during early or late gestation on schizophrenia-related behaviour in adult rat offspring","volume":"63","author":"Meehan","year":"2017","journal-title":"Brain Behav Immun"},{"key":"B204","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/schbul\/sby024","article-title":"Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations","volume":"44","author":"Mueller","year":"2018","journal-title":"Schizophrenia Bull"},{"key":"B205","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.pnpbp.2018.09.011","article-title":"Maternal immune activation in rats blunts brain cytokine and kynurenine pathway responses to a second immune challenge in early adulthood","volume":"89","author":"Clark","year":"2019","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B206","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.intimp.2013.08.007","article-title":"Increased cell-mediated immunity in male mice offspring exposed to maternal immune activation during late gestation","volume":"17","author":"Zager","year":"2013","journal-title":"Int Immunopharmcol"},{"key":"B207","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/hmg\/ddx432","article-title":"Systematic genetic interaction studies identify histone demethylase UTX as potential target for ameliorating Huntington's disease","volume":"27","author":"Song","year":"2018","journal-title":"Hum Mol Genet"},{"key":"B208","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neulet.2015.10.060","article-title":"DNA methylation in Huntington's disease: implications for trans-generational effects","volume":"625","author":"Thomas","year":"2016","journal-title":"Neurosci Lett"},{"key":"B209","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.brainres.2013.02.012","article-title":"Histone deacetylase class II and acetylated core histone immune-histochemistry in human brains with Huntington's disease","volume":"1504","author":"Yeh","year":"2013","journal-title":"Brain Res"},{"key":"B210","doi-asserted-by":"publisher","first-page":"6082","DOI":"10.1038\/s41598-017-05125-2","article-title":"A selective inhibitor of histone deacetylase 3 prevents cognitive deficits and suppresses striatal CAG repeat expansions in Huntington's disease mice","volume":"7","author":"Suelves","year":"2017","journal-title":"Sci Rep"},{"key":"B211","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.ajpath.2016.03.014","article-title":"DNA Methylation leads to DNA repair gene down-regulation and trinucleotide repeat expansion in patient-derived Huntington disease cells","volume":"186","author":"Mollica","year":"2016","journal-title":"Am J Pathol"},{"key":"B212","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1136\/annrheumdis-2015-209064","article-title":"Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes","volume":"76","author":"Angiolilli","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B213","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13075-017-1357-2","article-title":"Therapeutic effect of a novel histone deacetylase 6 inhibitor, CKD-L, on collagen-induced arthritis in vivo and regulatory T cells in rheumatoid arthritis in vitro","volume":"19","author":"Oh","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B214","doi-asserted-by":"publisher","first-page":"11849","DOI":"10.1038\/ncomms11849","article-title":"Joint-specific DNA methylation and transcriptome signatures in rheumatoid arthritis identify distinct pathogenic processes","volume":"7","author":"Ai","year":"2016","journal-title":"Nat Comm"},{"key":"B215","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.intimp.2017.02.008","article-title":"Aberrant methylation patterns affect the molecular pathogenesis of rheumatoid arthritis","volume":"46","author":"Lin","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"B216","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2217\/epi-2016-0042","article-title":"DNA methylation at diagnosis is associated with response to disease-modifying drugs in early rheumatoid arthritis","volume":"9","author":"Glossop","year":"2017","journal-title":"Epigenomics."},{"key":"B217","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.18632\/oncotarget.22918","article-title":"Comprehensive analysis of gene expression and DNA methylation datasets identify valuable biomarkers for rheumatoid arthritis progression","volume":"9","author":"Fang","year":"2018","journal-title":"Oncotarget."},{"key":"B218","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1080\/08820139.2018.1480029","article-title":"Analysis of Helios gene expression and Foxp3 TSDR methylation in the newly diagnosed rheumatoid arthritis patients","volume":"47","author":"Zafari","year":"2018","journal-title":"Immunol Invest"},{"key":"B219","first-page":"314","article-title":"Altered gene expression profiles of histone lysine methyltransferases and demethylases in rheumatoid arthritis synovial fibroblasts","volume":"36","author":"Araki","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"B220","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/art.39590","article-title":"Differential methylation as a biomarker of response to etanercept in patients with rheumatoid arthritis","volume":"68","author":"Plant","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B221","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.2174\/0929867324666170502123114","article-title":"Major developments in the design of inhibitors along the kynurenine pathway","volume":"24","author":"Jacobs","year":"2017","journal-title":"Curr Med Chem"},{"key":"B222","doi-asserted-by":"publisher","first-page":"8762","DOI":"10.1021\/acs.jmedchem.5b00461","article-title":"Challenges and opportunities in the discovery of new therapeutics targeting the kynurenine pathway","volume":"26","author":"Dounay","year":"2015","journal-title":"J Med Chem"},{"key":"B223","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fmolb.2019.00003","article-title":"Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition","volume":"6","author":"Phillips","year":"2019","journal-title":"Front Molec Biosci"},{"key":"B224","doi-asserted-by":"publisher","first-page":"15827","DOI":"10.1038\/ncomms15827","article-title":"Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase","volume":"8","author":"Hutchinson","year":"2017","journal-title":"Nature Commun"},{"key":"B225","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1021\/acs.jmedchem.7b00055","article-title":"Development of a series of kynurenine 3-monooxygenase inhibitors leading to a clinical candidate for the treatment of acute pancreatitis","volume":"60","author":"Walker","year":"2017","journal-title":"J Med Chem"},{"key":"B226","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.1016\/j.bmcl.2016.10.058","article-title":"First molecular modeling report on novel arylpyrimidine kynurenine monooxygenase inhibitors through multi-QSAR analysis against Huntington's disease: A proposal to chemists!","volume":"26","author":"Amin","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"B227","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fmolb.2019.00007","article-title":"The synthesis of kynurenic acid in mammals: an updated kynurenine aminotransferase structural katalogue","volume":"6","author":"Rossi","year":"2019","journal-title":"Front Molec Biosci"},{"key":"B228","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3390\/molecules21070856","article-title":"Study of the activity and possible mechanism of action of a reversible inhibitor of recombinant human KAT-2: a promising lead in neurodegenerative and cognitive disorders","volume":"21","author":"Nematollahi","year":"2016","journal-title":"Molecules"},{"key":"B229","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1021\/acs.jmedchem.7b01254","article-title":"Alpha-Amino-beta-carboxymuconate-epsilon-semialdehyde Decarboxylase (ACMSD) inhibitors as novel modulators of de novo nicotinamide adenine dinucleotide (NAD(+)) biosynthesis","volume":"61","author":"Pellicciari","year":"2018","journal-title":"J Med Chem"},{"key":"B230","doi-asserted-by":"publisher","first-page":"10243","DOI":"10.1038\/s41598-019-46666-y","article-title":"Selective and competitive inhibition of kynurenine aminotransferase 2 by glycyrrhizic acid and its analogues","volume":"9","author":"Yoshida","year":"2019","journal-title":"Sci Rept"},{"key":"B231","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1016\/j.bmc.2019.05.048","article-title":"Design, synthesis and biological evaluation of novel aryl-acrylic derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors","volume":"27","author":"Hu","year":"2019","journal-title":"Bioorg Med Chem"},{"key":"B232","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.1016\/j.bmc.2018.08.028","article-title":"Design, synthesis and structure-activity relationship study of novel naphthoindolizine and indolizinoquinoline-5,12-dione derivatives as IDO1 inhibitors","volume":"26","author":"Yang","year":"2018","journal-title":"Bioorg Med Chem"},{"key":"B233","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ejmech.2018.08.013","article-title":"Design, synthesis and biological evaluation of novel naphthoquinone derivatives as IDO1 inhibitors","volume":"157","author":"Pan","year":"2018","journal-title":"Europ J Med Chem"},{"key":"B234","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ejmech.2017.09.025","article-title":"Discovery of imidazoleisoindole derivatives as potent IDO1 inhibitors: Design, synthesis, biological evaluation and computational studies","volume":"140","author":"Zou","year":"2017","journal-title":"Europ J Med Chem"},{"key":"B235","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1016\/j.bmc.2017.05.017","article-title":"Identification and preliminary structure-activity relationships of 1-Indanone derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors","volume":"25","author":"Gao","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"B236","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuropharm.2016.08.003","article-title":"The kynurenine pathway and the brain: challenges, controversies and promises","volume":"112","author":"Schwarcz","year":"2017","journal-title":"Neuropharmacology."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00388\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T23:48:23Z","timestamp":1695858503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00388\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":236,"alternative-id":["10.3389\/fimmu.2020.00388"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00388","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,5]]},"article-number":"388"}}